Skip to main content
Carl Crawford, MD, Gastroenterology, New York, NY, New York-Presbyterian Hospital

CarlVictorCrawfordMD

Gastroenterology • New York, NY

Advanced Endoscopic Interventional, Inflammatory Bowel Disease

Assistant Professor, Medicine, Weill Cornell Medical College

Request Appointment

Overview of Dr. Crawford

Dr. Carl Crawford is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and Memorial Sloan Kettering Cancer Center. He received his medical degree from Yale School of Medicine and has been in practice 16 years. He is one of 299 doctors at New York-Presbyterian Hospital and one of 37 doctors at Memorial Sloan Kettering Cancer Center who specialize in Gastroenterology. He has more than 40 publications and over 500 citings.

Education & Training

  • Yale School of Medicine
    Yale School of MedicineClass of 2001
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Advanced Endoscopy

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2004 - 2025

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • To Scope or Not to Scope? The Safety of Upper Endoscopy in the Setting of Pulmonary Embolism  
    Russell Rosenblatt, Zaid Tafesh, David Wan, Carl Crawford, Nature
  • Gut Microbiota Dysbiosis and Diarrhea in Kidney Transplant Recipients  
    Eric Pamer, Manikkam Suthanthiran, Ying Taur, Michael J Satlin, Darshana Dadhania, John Richard Lee, Carl Crawford, Michelle Lubetzky, American journal of transplantation

Lectures

  • Update in Gastroenterology, Hepatology & Nutrition , 29th Annual Postgraduate Medicine Course 
    College of Physicians & Surgeons, Columbia University, New York, New York - 11/30/2012

Press Mentions

  • Vowst Becomes First FDA-Approved Fecal Microbiota Pill
    Vowst Becomes First FDA-Approved Fecal Microbiota PillApril 27th, 2023
  • FDA OKs First Poop-Based Oral Therapy
    FDA OKs First Poop-Based Oral TherapyApril 27th, 2023
  • Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWSTTM (Fecal Microbiota Spores, Live-Brpk) for Prevention of Recurrence of C. Difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI
    Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWSTTM (Fecal Microbiota Spores, Live-Brpk) for Prevention of Recurrence of C. Difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDIApril 26th, 2023
  • Join now to see all

Hospital Affiliations

Dr. Carl Crawford, Dr. Carl Crawford, MD, Dr. C Crawford, Dr. Carl Victor Crawford